7月 2026
- 首頁
- Shilpa Medicare
7月 2026Shilpa Medicare的市場佔有率分析
custom peptide synthesis|shilpa avers that all business enterprises share a symbiotic relationship with society from where they draw resources for their growth. it is imperative upon enterprises to return their mite to the society and therefore there is a duty to fulfill to the communities, neighborhoods and environment in whose vicinity they operate.not only being an enterprise engaged in medicare directed towards bettering lives, shilpa wholesomely subscribes to the motto of societal obligation and is committed to materializing initiatives through practical steps also, that spell a change in the life and quality of the communities and protects the environment too.
Shilpa Medicare(包含公司地區)
查看更多網站流量與參與度資訊- vbshilpa.com
Shilpa Medicare截至 7月 2026 的總收入為 100M - 200M
Shilpa Medicare 熱門網域產生的總收入
Shilpa Medicare 熱門網域 3 年內的總收入
Shilpa Medicare 熱門網域的總收入
Shilpa Medicare的熱門網域總造訪量
了解Shilpa Medicare市場觸達率與潛在市場影響力。
過去 3 個月的訪問總量
子公司細目
Shilpa Medicare的熱門網域平均造訪時長
分析Shilpa Medicare參與度指標。
過去 3 個月平均造訪時長
子公司細目
Shilpa Medicare的熱門網域平均頁面瀏覽量
了解Shilpa Medicare如何保持使用者的參與度、培養其興趣,並鼓勵他們採取下一步。
過去 3 個月平均頁面瀏覽量
子公司細目
想要取得更深入的流量洞見?
篩選超過 2,030 萬家線上企業。在流量激增、開始或停止使用技術或獲得正面評價時,發現新的潛在客戶。
新聞與訊號來自Shilpa Medicare
透過 Similarweb 銷售訊號提醒,每當目標受眾出現新的機會或威脅時,你就會收到每日更新的已識別購買訊號。
新聞Shilpa Medicare Limited had earnings of $163M on Jul 1st '26.For the financial year 2026, Shilpa Medicare Limited reported a total income of ₹1,548.71 crore.
8月 5, 2026閱讀更多
新聞Shilpa Medicare Limited is developing nivolumab biosimilar for Europe on Jul 6th '26.Orion and Shilpa Medicare expand partnership to develop and supply nivolumab biosimilar for Europe.
7月 7, 2026閱讀更多
查看所有Shilpa Medicare信號
讓銷售團隊專注於最有希望的機會。透過安排機會的優先順序,並在正確的時間參與,您可將工作最佳化,並完成更多交易。
